Prescription Required
Formulation: Tablet
Prescription Required
Formulation: Tablet
(Generic Alternative)
Select the prescribed dosage
Select the quantity to see the price.
* This price includes a dispensing fee, medical review fee, and packing fee.
Shipped and delivered directly to your doorstep
Nozinan is a prescription medication used to manage certain psychiatric conditions, severe nausea and vomiting, and specific types of pain.
It contains methotrimeprazine, also known as levomepromazine, an active ingredient that affects chemical messengers in the brain and nervous system.
Nozinan belongs to a class of medications called first-generation (typical) antipsychotics, specifically the phenothiazine group. These medications help regulate the activity of certain neurotransmitters, particularly dopamine.
Dopamine is a chemical messenger involved in mood, thinking, movement, behavior, and the body’s nausea and vomiting response.
By blocking certain dopamine receptors, Nozinan can help reduce psychotic symptoms and control nausea and vomiting.
Nozinan also affects other receptors involved in sedation, pain perception, and blood pressure regulation.
Because of these effects, the medication may be used in selected patients who require additional symptom control.
Nozinan can help manage psychotic symptoms, severe nausea and vomiting, and certain pain conditions. However, it may cause significant drowsiness, low blood pressure, and other serious side effects, so medical supervision is essential.Â
Nozinan is used to manage symptoms associated with certain psychotic disorders.
Psychosis is a condition in which a person experiences difficulty distinguishing between what is real and what is not.
Symptoms may include hallucinations, delusions, disorganized thinking, and significant behavioral disturbances.
Hallucinations involve seeing, hearing, or sensing things that are not present. Delusions are strongly held beliefs that do not reflect reality and persist despite evidence to the contrary.
Some individuals may also experience severe agitation, confusion, or unusual changes in behavior.
Nozinan helps reduce certain psychotic symptoms by blocking dopamine receptors in the brain.
Its sedating effects may also help calm severe agitation when clinically appropriate.
However, Nozinan does not cure the underlying psychiatric condition, and its effectiveness varies depending on the diagnosis and individual response.
Your healthcare provider will determine whether Nozinan is appropriate based on symptom severity, medical history, and other treatment options.
Nozinan may help control hallucinations, delusions, and severe agitation associated with certain psychotic disorders, but it should only be used under medical supervision.
Nozinan may be prescribed to manage symptoms associated with schizophrenia.
Schizophrenia is a chronic psychiatric condition that affects thinking, perception, emotional responses, and behavior.
People with schizophrenia may experience hallucinations, delusions, disorganized speech, or difficulty organizing their thoughts.
Some individuals may also have reduced motivation, social withdrawal, or difficulty carrying out everyday activities.
Nozinan works partly by blocking dopamine D2 receptors, which are involved in the development of certain psychotic symptoms.
This may help reduce hallucinations, delusions, and agitation.
Its sedating properties can be useful in selected patients experiencing significant restlessness or behavioral disturbances.
However, Nozinan can cause substantial sedation and other side effects, so it may not be the preferred long-term antipsychotic for every patient.
Your healthcare provider will consider the benefits and risks before prescribing it.
Nozinan may help manage certain symptoms of schizophrenia, but ongoing psychiatric assessment is necessary to evaluate treatment effectiveness and safety.
Nozinan may also be used to control severe nausea and vomiting, particularly when symptoms originate from signals involving the brain’s vomiting pathways.
Nausea is an unpleasant sensation that may occur before vomiting.
Vomiting is a reflex that removes stomach contents through the mouth and can be triggered by several medical conditions.
Certain areas of the brain are involved in detecting substances and signals that stimulate nausea and vomiting.
Dopamine receptors play an important role in these pathways.
Nozinan blocks certain dopamine receptors, helping reduce the brain’s response to nausea-related signals.
This can make it useful in selected patients with persistent or difficult-to-control nausea.
For example, Nozinan may be prescribed in palliative care when nausea is caused by several contributing factors or has not responded adequately to other treatments.
However, not every type of nausea requires Nozinan, and other antiemetic medications may be more suitable depending on the underlying cause.
Nozinan may help control severe or persistent nausea and vomiting, particularly when other treatments are insufficient or unsuitable.Â
Nozinan may be used as an additional medication in the management of certain types of severe or persistent pain.
Unlike conventional pain relievers such as acetaminophen or ibuprofen, Nozinan acts primarily on neurotransmitter receptors in the central nervous system.
It has sedative and analgesic properties that may provide additional symptom relief in selected patients.
Historically, methotrimeprazine has been used for pain associated with cancer, shingles, certain neuralgias, and phantom limb pain.
Neuralgia refers to pain caused by irritation or damage to a nerve.
Phantom limb pain is pain perceived in a body part that has been amputated.
In some cases, Nozinan may be prescribed alongside other pain medications to help improve comfort.
However, evidence supporting its analgesic benefits varies, and Nozinan is not generally considered a first-line treatment for ordinary pain.
Because it can cause significant sedation, low blood pressure, and other adverse effects, its use requires an individualized assessment.
Nozinan may be used as an adjunct for selected pain conditions, but it does not replace standard pain management treatments.Â
Nozinan is sometimes used in palliative care to help manage distressing symptoms associated with serious or advanced illnesses.
Palliative care focuses on improving comfort and quality of life for patients experiencing significant symptoms.
Some patients may experience several symptoms at the same time, including persistent nausea, agitation, pain, and difficulty sleeping.
Nozinan has sedative, antiemetic, and antipsychotic effects, which may make it useful when multiple symptoms require treatment.
For example, a healthcare provider may consider Nozinan for severe nausea that has not responded to other medications.
It may also be used in carefully selected patients experiencing significant agitation or distress.
The dosage and method of administration depend on the patient’s symptoms, physical condition, and goals of care.
Because Nozinan can cause marked drowsiness, its use must balance symptom relief with the patient’s comfort and desired level of alertness.
Nozinan may help manage selected symptoms in palliative care, but treatment should be individualized and closely supervised by a healthcare provider.
Nozinan contains methotrimeprazine, a phenothiazine medication that affects several chemical receptors in the brain and body.
Its therapeutic effects result from interactions with neurotransmitters involved in thinking, behavior, nausea, and other bodily functions.
Blocks Dopamine Receptors
Nozinan blocks certain dopamine receptors, particularly D2 receptors.
This action helps reduce some psychotic symptoms and contributes to its anti-nausea effects.
Produces Sedative Effects
Nozinan also blocks histamine H1 receptors, which contributes to its sedating properties.
This may help reduce severe agitation or restlessness, but it can also cause significant drowsiness.
Affects Other Neurotransmitter Receptors
Nozinan interacts with alpha-adrenergic and muscarinic receptors.
These effects contribute to certain therapeutic actions and side effects, including low blood pressure, dry mouth, constipation, and urinary difficulties.
Provides Additional Symptom Relief
Because Nozinan acts on several receptor systems, it may help control more than one symptom in selected patients.
However, this broad activity also increases the potential for adverse effects and drug interactions.
Nozinan works by blocking dopamine and several other neurotransmitter receptors, helping manage psychotic symptoms, nausea, and certain other distressing symptoms.
The time needed for Nozinan to produce noticeable effects depends on the reason for treatment, the dosage, and the method of administration.
Some effects, particularly sedation and relief of agitation, may occur relatively soon after the medication is administered.
The anti-nausea effects may also develop within hours, depending on the formulation and individual response.
However, improvement in psychotic symptoms may take several days or weeks.
Patients being treated for schizophrenia or another psychiatric condition may require continued treatment and regular reassessment before the full benefits can be evaluated.
Your healthcare provider may adjust the dosage based on symptom control, side effects, and overall treatment goals.
Continue taking Nozinan according to your prescribed schedule and do not change your dosage without medical guidance.
Nozinan is available in different formulations, including oral and injectable products, although availability varies by country.
The appropriate dosage depends on the condition being treated, symptom severity, patient age, medical history, and response to treatment.
Common side effects include drowsiness, dizziness, dry mouth, constipation, and low blood pressure.
More serious complications may include abnormal heart rhythms, movement disorders, seizures, and neuroleptic malignant syndrome, a rare but potentially life-threatening reaction to antipsychotic medications.
Nozinan may also increase the sedating effects of alcohol, opioids, sleeping pills, and certain other medications.
Older adults, particularly those with dementia, require special caution. Nozinan is not indicated for treating dementia-related behavioral disturbances, and antipsychotics may increase mortality risk in older patients with dementia.
Do not stop Nozinan suddenly without consulting your healthcare provider, particularly after regular or prolonged use.
Seek emergency medical attention if you develop severe muscle stiffness with fever and confusion, fainting, difficulty breathing, or a rapid or irregular heartbeat.
Nozinan should only be used under medical supervision, with regular evaluation of its benefits, potential side effects, and interactions with other medications.
Nozinan is a prescription medication used to manage certain psychiatric conditions, severe nausea and vomiting, and selected types of pain.
It belongs to a class of medications called phenothiazine antipsychotics, which affect chemical messengers in the brain involved in mood, thinking, nausea, and other bodily functions.
Nozinan tablets are taken by mouth, usually with or without food, according to your healthcare provider’s instructions.
The appropriate dosage and frequency depend on several factors, including the condition being treated, age, medical history, other medications, and individual response.
Because Nozinan can cause significant drowsiness, dizziness, and low blood pressure, treatment is often started at a lower dose and adjusted gradually when necessary.
Dosages used for psychiatric conditions may be substantially different from those used for nausea or palliative care.
Take Nozinan exactly as prescribed. Do not increase, reduce, or stop taking the medication without consulting your healthcare provider.
Nozinan tablets are intended for oral administration and should be taken according to the instructions on your prescription label.
Swallow the prescribed dose with a glass of water.
The tablets can generally be taken with or without food. If you experience mild stomach discomfort, taking Nozinan with a meal may help.
Some Nozinan tablets are scored and may be divided when appropriate. Whether a particular tablet can be split or crushed depends on its formulation, so ask your pharmacist before altering it.
Your healthcare provider may recommend taking Nozinan at specific times throughout the day, depending on your symptoms and the prescribed dosage.
Because the medication can cause drowsiness, certain doses may be scheduled at bedtime.
However, do not change your dosing times without medical advice.
Try to take your medication consistently to help maintain symptom control.
Follow the administration instructions for your specific Nozinan product, and ask your pharmacist before crushing, chewing, or splitting the tablets.
The recommended dosage of Nozinan varies considerably depending on the condition being treated.
Methotrimeprazine may be prescribed for psychiatric conditions, severe nausea, or certain pain-related symptoms.
These conditions can require very different treatment schedules.
For adults receiving treatment for severe psychiatric symptoms, some regimens may begin with approximately 25 mg to 50 mg per dose, taken two or three times daily.
However, this is not an appropriate starting dose for every patient or every indication.
Patients receiving Nozinan for nausea or palliative symptom management may require substantially lower doses.
Older adults and patients with certain medical conditions may also require lower starting doses because they can be more sensitive to sedation and low blood pressure.
Your healthcare provider will determine the appropriate dosage based on your symptoms, overall health, and treatment goals.
The dosage may be adjusted gradually depending on symptom control and side effects.
Do not use a general dosage range to determine how much Nozinan to take. Always follow the specific dose prescribed for your condition.
Nozinan may be started at a low dose to help reduce the likelihood of unwanted side effects.
This approach is particularly important because methotrimeprazine affects several chemical receptors in the brain and body.
These effects contribute to its therapeutic benefits but may also cause drowsiness, dizziness, dry mouth, constipation, and low blood pressure.
A low starting dose allows your healthcare provider to assess how you respond to the medication.
If your symptoms remain uncontrolled and the initial dose is well tolerated, your healthcare provider may recommend a gradual increase.
This process is called dose titration.
The appropriate titration schedule depends on the condition being treated and the patient’s individual response.
Do not increase your Nozinan dosage on your own, even if symptoms do not improve immediately.
Yes. Nozinan tablets can generally be taken with or without food.
Food is not usually necessary for the medication to work effectively.
However, some patients may experience nausea, stomach discomfort, or changes in appetite during treatment.
Taking Nozinan with a meal may help reduce mild stomach irritation in certain patients.
If you experience persistent nausea or vomiting, contact your healthcare provider rather than adjusting your medication independently.
Avoid alcohol while taking Nozinan because alcohol can increase its sedating effects and raise the risk of dizziness, impaired coordination, and low blood pressure.
Take Nozinan with or without food as directed by your healthcare provider, and avoid alcohol during treatment.Â
The best time to take Nozinan depends on the condition being treated and your prescribed dosage.
Some patients may be instructed to take Nozinan two or three times daily, while others may receive a single dose at bedtime.
Nozinan has strong sedating properties, which can cause drowsiness and reduced alertness.
For this reason, your healthcare provider may recommend taking certain doses in the evening or before bedtime.
However, patients who require symptom control throughout the day may need a different dosing schedule.
Taking the medication consistently can help maintain its intended effects.
Avoid driving, operating heavy machinery, or performing activities that require concentration if you experience dizziness or drowsiness.
Take Nozinan at the times recommended by your healthcare provider. Do not change your dosing schedule solely to reduce sleepiness without medical advice.
If you forget to take a dose of Nozinan, take it as soon as you remember, unless it is almost time for your next scheduled dose.
If your next dose is approaching, skip the missed dose and continue with your regular schedule.
Do not take two doses together to make up for a missed tablet.
Taking additional methotrimeprazine may increase the risk of excessive sedation, dangerously low blood pressure, and other serious side effects.
If you are taking Nozinan for ongoing psychiatric treatment, repeatedly missing doses may reduce symptom control.
If you use Nozinan for nausea, pain, or palliative care, your healthcare provider may provide different instructions based on your treatment plan.
If you miss several consecutive doses or are unsure how to restart treatment, contact your healthcare provider or pharmacist.
Never double your Nozinan dose to make up for a missed dose.
Older adults may be more sensitive to the effects of Nozinan, particularly sedation and low blood pressure.
As people age, changes in organ function and medication sensitivity may affect how the body responds to treatment.
Nozinan can cause orthostatic hypotension, a sudden drop in blood pressure when standing up.
This may cause dizziness, weakness, or fainting.
Older adults may also be more susceptible to confusion, constipation, urinary retention, and movement-related side effects.
These effects can increase the risk of falls and other complications.
For this reason, healthcare providers generally recommend lower initial doses and careful monitoring in older patients.
Nozinan is not indicated for treating behavioral disturbances associated with dementia, and antipsychotic medications may increase the risk of death in older adults with dementia.
Older adults should use Nozinan only under careful medical supervision, with dosage adjustments based on individual response and tolerance.Â
Before starting Nozinan, inform your healthcare provider if you have liver disease, heart disease, or another significant medical condition.
The liver helps process methotrimeprazine and other medications.
Patients with impaired liver function may be more sensitive to certain medication effects and may require additional monitoring.
Nozinan can also affect blood pressure and the electrical activity of the heart.
In some patients, it may cause abnormal heart rhythms or prolong the QT interval, an electrical measurement recorded on an electrocardiogram (ECG).
The risk of heart-related complications may be greater in patients with existing cardiovascular disease, electrolyte abnormalities, or those taking other medications that affect heart rhythm.
Your healthcare provider may recommend an ECG, blood tests, or additional monitoring before or during treatment.
Tell your healthcare provider if you have heart disease, liver disease, low blood pressure, or a history of abnormal heart rhythms before taking Nozinan.
Yes. Nozinan may interact with several prescription medications, over-the-counter products, and supplements.
Some interactions can increase sedation, lower blood pressure, or affect heart rhythm.
Combining Nozinan with opioids, sleeping pills, benzodiazepines, or other medications that depress the central nervous system may cause excessive drowsiness and potentially dangerous breathing problems.
Other medications with anticholinergic properties may increase the risk of dry mouth, constipation, blurred vision, or urinary retention.
Certain medications that prolong the QT interval may increase the risk of serious abnormal heart rhythms when combined with Nozinan.
Your healthcare provider will review your complete medication list to identify potential interactions.
Tell your healthcare provider and pharmacist about all medications, vitamins, herbal supplements, and over-the-counter products you take before starting Nozinan.
Do not stop taking Nozinan suddenly without consulting your healthcare provider, particularly if you have been using the medication regularly for an extended period.
Abrupt discontinuation may cause withdrawal-related symptoms such as nausea, vomiting, sweating, restlessness, or difficulty sleeping.
If Nozinan is being used to manage psychotic symptoms, stopping treatment may also allow the underlying psychiatric condition to worsen.
Patients taking Nozinan for nausea or other symptoms may experience a return of those symptoms after treatment is discontinued.
Your healthcare provider will determine whether the medication needs to be gradually reduced.
The appropriate discontinuation schedule depends on your dosage, treatment duration, and medical condition.
Do not stop or reduce Nozinan without medical guidance. Your healthcare provider can recommend a safe treatment adjustment when necessary.
Nozinan can cause significant drowsiness, dizziness, low blood pressure, dry mouth, constipation, and blurred vision.
More serious complications may include abnormal heart rhythms, movement disorders, seizures, and neuroleptic malignant syndrome.
Neuroleptic malignant syndrome is a rare but potentially life-threatening reaction that may cause high fever, severe muscle stiffness, confusion, and changes in heart rate or blood pressure.
Seek emergency medical attention if you develop severe muscle stiffness with fever, difficulty breathing, fainting, seizures, or a rapid or irregular heartbeat accompanied by severe weakness.
Take Nozinan only according to your prescribed dosage and schedule. Attend recommended follow-up appointments so your healthcare provider can assess symptom control, medication tolerance, and possible side effects.
Nozinan (methotrimeprazine) is available in the following forms and strength:
Nozinan is a prescription medication used to manage certain psychiatric conditions, severe nausea and vomiting, and selected types of pain.
It belongs to a class of medications called phenothiazine antipsychotics, which affect chemical messengers in the brain and nervous system.
Although Nozinan can help control certain symptoms, it may also cause significant side effects, including drowsiness, low blood pressure, movement disorders, and changes in heart rhythm.
Some patients may require additional precautions because of their age, medical conditions, or other medications.
Nozinan should only be used under medical supervision. Tell your healthcare provider about your complete medical history and all medications you take before starting treatment.
Nozinan should be used with caution in patients who have liver disease or impaired liver function.
The liver helps process many medications, including methotrimeprazine.
When liver function is reduced, the body may process certain medications more slowly, potentially increasing their effects or the risk of adverse reactions.
Nozinan can also occasionally cause liver-related complications, including abnormal liver function tests and cholestatic jaundice.
Cholestatic jaundice occurs when the normal flow of bile from the liver is disrupted, causing bilirubin to accumulate in the bloodstream.
Symptoms of liver problems may include unusual fatigue, persistent nausea, loss of appetite, dark urine, pale stools, or yellowing of the skin and eyes.
Patients with existing liver disease may require a lower dosage, closer monitoring, or an alternative treatment.
Your healthcare provider may recommend liver function tests based on your condition and treatment duration.
Tell your healthcare provider if you have liver disease before taking Nozinan. Seek prompt medical assessment if you develop jaundice, dark urine, or other signs of liver injury.
Patients with heart disease should use Nozinan under careful medical supervision.
Methotrimeprazine can affect blood pressure, heart rate, and electrical activity within the heart.
These effects may be particularly concerning for patients with existing cardiovascular disease, heart rhythm disorders, or reduced heart function.
Some patients may experience palpitations, dizziness, or a sudden decrease in blood pressure.
In certain circumstances, Nozinan may also affect the heart’s electrical recovery period, increasing the risk of abnormal heart rhythms.
Your healthcare provider may recommend an electrocardiogram (ECG) to assess heart rhythm before or during treatment.
Blood tests may also be needed to check electrolyte levels, particularly potassium and magnesium, because abnormalities can increase the risk of serious arrhythmias.
Tell your healthcare provider if you have heart disease, a history of fainting, or an abnormal heart rhythm before taking Nozinan. Seek emergency medical attention for severe chest pain, fainting, or a rapid or irregular heartbeat accompanied by weakness.
Nozinan requires particular caution in children and should not be given to infants unless a specialist determines that its use is appropriate under applicable prescribing guidance.
Young children may be more sensitive to the effects of medications that depress the central nervous system.
Nozinan can cause substantial sedation and may interfere with normal alertness and breathing.
In very young children, excessive sedation and respiratory depression can be particularly dangerous.
Respiratory depression means breathing becomes abnormally slow, shallow, or ineffective.
Symptoms may include unusually slow breathing, difficulty waking, limpness, or bluish discoloration around the lips.
Nozinan is not a routine medication for infants, and product-specific pediatric restrictions must be followed.
The original warning about respiratory depression refers to reduced breathing, not the mental health condition of depression.
Do not give Nozinan to an infant or young child without explicit specialist instructions. Seek emergency medical attention if a child becomes difficult to wake or develops slow or abnormal breathing.
Nozinan may cause significant drowsiness, dizziness, or reduced alertness.
These effects occur partly because methotrimeprazine blocks histamine receptors and affects other chemical messengers in the nervous system.
Some patients may feel unusually sleepy, lightheaded, or less able to concentrate.
These symptoms may be more noticeable when treatment begins or after a dosage increase.
Taking Nozinan with alcohol, sleeping pills, opioids, or other sedating medications may make these effects more severe.
Drowsiness and dizziness may interfere with driving, operating machinery, or performing tasks that require coordination and concentration.
Patients may also experience an increased risk of falls, particularly when standing up suddenly.
Avoid driving, operating heavy machinery, or performing potentially dangerous activities until you know how Nozinan affects you. Seek medical advice if drowsiness or dizziness becomes severe or persistent.
Older adults may be more sensitive to the effects of Nozinan, particularly its sedating, blood pressure-lowering, and anticholinergic properties.
As people age, changes in medication metabolism and increased sensitivity to certain drugs can affect treatment tolerance.
Older patients may experience excessive sleepiness, confusion, dizziness, constipation, dry mouth, or difficulty urinating.
Nozinan may also cause orthostatic hypotension, which is a sudden drop in blood pressure when standing.
This can increase the risk of falls and injuries.
Healthcare providers often recommend lower starting doses and gradual adjustments in older adults.
Special caution is necessary for older patients with dementia.
Antipsychotic medications have been associated with an increased risk of death in older adults with dementia-related psychosis.
Nozinan is not routinely indicated for treating behavioral disturbances associated with dementia.
Older adults should use Nozinan only under careful medical supervision, with regular assessment of sedation, blood pressure, mobility, and other potential side effects.
Nozinan may interact with certain prescription medications, over-the-counter drugs, and herbal supplements.
Some interactions may increase drowsiness, interfere with breathing, lower blood pressure, or affect the heart’s electrical activity.
Particular caution is necessary when Nozinan is combined with medications that depress the central nervous system.
These include benzodiazepines, such as diazepam and lorazepam, and opioid pain medications, such as morphine, oxycodone, and fentanyl.
Combining these medications may cause excessive sedation, confusion, impaired coordination, or respiratory depression.
Respiratory depression occurs when breathing becomes abnormally slow or shallow.
Nozinan may also interact with medications that have anticholinergic properties, including certain antihistamines, antidepressants, and bladder medications.
These combinations may increase the risk of dry mouth, constipation, blurred vision, confusion, and urinary retention.
Other medications that prolong the QT interval may increase the risk of dangerous heart rhythm disturbances.
Alcohol can further increase the sedating and blood pressure-lowering effects of Nozinan and should be avoided during treatment.
Tell your healthcare provider and pharmacist about all medications, vitamins, herbal supplements, and over-the-counter products you take. Seek emergency medical attention if you develop severe drowsiness, difficulty breathing, or loss of consciousness.Â
Nozinan may cause extrapyramidal symptoms, which are movement-related side effects associated with certain antipsychotic medications.
These effects occur because methotrimeprazine blocks dopamine receptors involved in controlling normal muscle movement.
Dopamine is a chemical messenger that helps regulate movement, coordination, and muscle activity.
When dopamine activity is reduced, some patients may develop involuntary movements, muscle stiffness, or restlessness.
One possible reaction is drug-induced parkinsonism, which may cause tremors, slowed movements, muscle rigidity, or a shuffling walking pattern.
Another reaction is akathisia, a condition involving uncomfortable inner restlessness and a strong urge to keep moving.
Some patients may also develop acute dystonia, which causes sudden, involuntary muscle contractions. These may affect the neck, jaw, tongue, eyes, or other muscles.
A separate concern is tardive dyskinesia, which may develop after prolonged exposure to antipsychotic medications.
Tardive dyskinesia causes repetitive, involuntary movements, such as lip-smacking, tongue movements, facial grimacing, or abnormal movements of the arms and legs.
These symptoms may persist even after the medication is discontinued.
The risk varies depending on the dosage, treatment duration, age, and individual susceptibility.
Your healthcare provider may recommend reducing the dosage, changing medications, or providing treatment for movement-related side effects.
Contact your healthcare provider promptly if you develop tremors, muscle stiffness, restlessness, or unusual involuntary movements. Seek emergency medical attention if muscle spasms interfere with breathing or swallowing.Â
Nozinan should be used cautiously in patients with epilepsy or a history of seizures.
A seizure occurs when abnormal electrical activity in the brain causes sudden changes in movement, awareness, sensation, or consciousness.
Symptoms may include involuntary shaking, muscle stiffness, confusion, or temporary loss of consciousness.
Methotrimeprazine belongs to the phenothiazine class of medications, which may lower the seizure threshold in some patients.
The seizure threshold refers to the level of brain activity required to trigger a seizure.
When this threshold is reduced, seizures may occur more easily in susceptible individuals.
Patients with an existing seizure disorder may therefore require closer monitoring during Nozinan treatment.
Your healthcare provider will consider your seizure history, current antiepileptic medications, and the potential benefits and risks of treatment.
Do not discontinue prescribed seizure medications without medical guidance.
Tell your healthcare provider if you have epilepsy or previously experienced seizures. Seek emergency medical attention for a seizure lasting five minutes or longer, repeated seizures without recovery, or a first-time seizure.Â
Nozinan may cause a significant decrease in blood pressure, particularly when treatment begins or the dosage is increased.
This effect occurs partly because methotrimeprazine blocks alpha-adrenergic receptors involved in regulating blood vessel tone.
When blood vessels relax, blood pressure may decrease.
Some patients may develop orthostatic hypotension, which occurs when blood pressure drops suddenly after standing up.
Symptoms may include dizziness, lightheadedness, weakness, blurred vision, or fainting.
These effects may be especially noticeable during the first few days of treatment.
Older adults, patients who are dehydrated, and those taking blood pressure medications may be more susceptible.
To reduce dizziness, stand up slowly from sitting or lying positions.
If you feel lightheaded, sit or lie down until the symptoms improve.
Your healthcare provider may recommend regular blood pressure monitoring or dosage adjustments.
Contact your healthcare provider if you experience repeated dizziness or low blood pressure. Seek emergency medical attention if you faint, become severely confused, or develop signs of circulatory collapse.Â
Nozinan may affect the electrical activity of the heart and increase the risk of certain abnormal heart rhythms.
One potential complication is QT prolongation.
The QT interval is a measurement on an electrocardiogram (ECG) that reflects how long the lower chambers of the heart take to electrically activate and recover.
When this interval becomes excessively prolonged, the risk of serious heart rhythm disturbances may increase.
A potentially life-threatening arrhythmia associated with QT prolongation is called torsades de pointes.
This condition can cause a rapid, unstable heartbeat that interferes with normal blood circulation.
Symptoms may include palpitations, severe dizziness, fainting, or sudden loss of consciousness.
Patients with existing heart rhythm disorders, congenital long QT syndrome, or low potassium or magnesium levels may have an increased risk.
The risk may also rise when Nozinan is combined with other medications that prolong the QT interval.
Your healthcare provider may recommend an ECG and blood tests before or during treatment, particularly if you have cardiovascular risk factors.
Tell your healthcare provider if you have a history of abnormal heart rhythms, unexplained fainting, or electrolyte imbalances. Seek emergency medical attention if you develop fainting, severe palpitations, or sudden loss of consciousness.Â
Nozinan may rarely cause agranulocytosis, a serious blood disorder involving a dangerously low number of certain white blood cells.
White blood cells help protect the body against infections.
Agranulocytosis primarily affects neutrophils, which are essential for defending against bacterial and fungal infections.
When neutrophil levels become severely reduced, the body may have difficulty fighting infections.
Even infections that would normally be mild can become serious.
Possible warning signs include fever, sore throat, chills, mouth ulcers, unusual weakness, or persistent infections.
In severe cases, agranulocytosis may lead to sepsis, a life-threatening condition caused by the body’s extreme response to an infection.
Other blood-related effects, including leukopenia and granulocytopenia, have also been reported with Nozinan.
Your healthcare provider may recommend a complete blood count before or during treatment when clinically appropriate.
However, routine frequent blood testing is not necessarily required for every patient. Monitoring depends on individual risk factors, symptoms, and treatment circumstances.
Contact your healthcare provider urgently if you develop a fever, sore throat, mouth ulcers, or other signs of infection while taking Nozinan. A blood count may be necessary to rule out a serious blood disorder.Â
Nozinan may interfere with the body’s ability to regulate temperature.
The brain normally helps maintain a stable body temperature by controlling sweating, blood circulation, and other physiological responses.
Methotrimeprazine affects neurotransmitter systems involved in these processes.
As a result, some patients may have difficulty adapting to changes in environmental temperature.
In cold environments, reduced temperature regulation may contribute to hypothermia.
Hypothermia occurs when body temperature falls abnormally low, potentially affecting normal organ function.
Symptoms may include excessive coldness, shivering, confusion, unusual sleepiness, slowed movements, or difficulty speaking.
Older adults may be particularly vulnerable because they may have reduced temperature regulation, underlying medical conditions, or limited mobility.
Nozinan can also interfere with the body’s response to heat, increasing the risk of overheating or heatstroke in certain circumstances.
Patients should avoid prolonged exposure to extreme temperatures and maintain appropriate hydration.
Caregivers may need to monitor temperature-related symptoms in older adults or patients who cannot communicate discomfort effectively.
Seek urgent medical attention if you develop significant confusion, unusually low body temperature, severe overheating, or changes in consciousness while taking Nozinan.Â
Nozinan may occasionally cause photosensitivity, although this reaction is uncommon.
Photosensitivity occurs when the skin becomes unusually sensitive to sunlight or ultraviolet (UV) radiation.
Patients who develop photosensitivity may experience redness, itching, burning, or a sunburn-like reaction after exposure to sunlight.
These reactions may occur even after relatively short periods outdoors.
Photosensitivity may be more noticeable on areas commonly exposed to sunlight, such as the face, neck, arms, and hands.
To reduce the risk of skin reactions, avoid prolonged exposure to direct sunlight, particularly during periods of intense UV radiation.
Use a broad-spectrum sunscreen with SPF 30 or higher when outdoors.
Protective clothing, a wide-brimmed hat, and seeking shade may also help reduce exposure.
Avoid tanning beds and artificial UV sources if you develop increased skin sensitivity.
If you experience an unusual rash or severe skin reaction after sun exposure, contact your healthcare provider.
Protect your skin from excessive sunlight while taking Nozinan, and report persistent redness, burning, or unusual skin reactions to your healthcare provider.Â
Nozinan is a phenothiazine medication that may be used to manage certain psychiatric symptoms, severe nausea, and selected pain-related conditions.
Although it can provide symptom relief, treatment may cause significant sedation, low blood pressure, movement disorders, and other adverse effects.
Patients with heart disease, liver problems, epilepsy, blood disorders, or other serious medical conditions may require additional monitoring.
Combining Nozinan with alcohol, opioids, benzodiazepines, or other sedating medications may increase the risk of excessive drowsiness and breathing difficulties.
Patients should also be aware of rare but serious complications, including agranulocytosis, dangerous heart rhythm disturbances, and neuroleptic malignant syndrome.
Seek emergency medical attention if you experience severe muscle stiffness with fever, difficulty breathing, seizures, fainting, or a rapid or irregular heartbeat accompanied by severe weakness.
These precautions are not an exhaustive list of all potential side effects, warnings, or medication interactions associated with Nozinan. Always follow your healthcare provider’s instructions and report new or worsening symptoms promptly.
Nozinan should only be used during pregnancy or breastfeeding when a healthcare provider determines that the potential benefits outweigh the possible risks. Nozinan contains methotrimeprazine, also known as levomepromazine, a phenothiazine medication used to manage certain psychiatric conditions, severe nausea and vomiting, and selected types of pain. There is limited information about the safety of Nozinan during pregnancy. Methotrimeprazine may cross the placenta and expose the developing baby to the medication. The potential risks depend on several factors, including the prescribed dosage, duration of treatment, stage of pregnancy, and the mother’s medical condition. Exposure to antipsychotic medications during the third trimester may cause temporary symptoms in newborn babies, including muscle stiffness, tremors, unusual movements, excessive sleepiness, feeding difficulties, or breathing problems. Some newborns may require additional medical observation after delivery. However, untreated serious psychiatric conditions and other illnesses may also pose risks during pregnancy. Your healthcare provider will carefully evaluate the potential benefits and risks before recommending Nozinan. During breastfeeding, methotrimeprazine may pass into breast milk, although information about the amount transferred and its effects on breastfed infants remains limited. Because Nozinan has significant sedating properties, there is concern about possible drowsiness, poor feeding, and other adverse effects in breastfed babies. Newborns and premature infants may be particularly vulnerable to medication exposure. Your healthcare provider may recommend an alternative medication or a different feeding plan, depending on your treatment needs and your baby’s health. If breastfeeding continues under specialist guidance, your baby may require monitoring for excessive sleepiness, feeding difficulties, or unusual changes in behavior. Do not start, stop, or change your Nozinan treatment during pregnancy or breastfeeding without medical guidance. Consult your healthcare provider to determine the safest treatment approach for you and your baby.
If you forget to take a dose of Nozinan, take it as soon as you remember, unless it is almost time for your next scheduled dose. If your next dose is approaching, skip the missed dose and continue with your regular dosing schedule. Do not take two doses together to make up for a missed tablet. Nozinan affects several chemical messengers in the brain and nervous system. Taking more medication than prescribed may increase the risk of excessive drowsiness, dizziness, low blood pressure, and other serious side effects. The appropriate missed-dose instructions may also depend on why Nozinan was prescribed. For example, patients taking the medication regularly for psychiatric symptoms may have a different treatment schedule from those receiving it for nausea or palliative care. If you have missed several consecutive doses, contact your healthcare provider before restarting your usual dosage. Taking Nozinan consistently is important for maintaining symptom control and reducing fluctuations in medication effects. To help prevent missed doses, consider setting a medication reminder or following a regular daily schedule. Never double your Nozinan dose to make up for a missed dose. If you are unsure when to take your next dose, ask your healthcare provider or pharmacist for advice.
Nozinan is not generally considered an addictive medication and is not known to produce the drug-seeking behavior or intense cravings commonly associated with addictive substances. However, this does not mean that treatment can always be stopped suddenly. Nozinan affects several neurotransmitter systems in the brain, including dopamine, histamine, and acetylcholine pathways. When the medication is taken regularly over an extended period, the body may gradually adjust to its effects. If treatment is stopped abruptly, some patients may experience withdrawal or discontinuation symptoms. Possible symptoms include nausea, vomiting, sweating, restlessness, anxiety, and difficulty sleeping. Insomnia may occur when the sedating effects of Nozinan are suddenly removed. Patients who have been taking Nozinan for psychiatric symptoms may also experience a return or worsening of their underlying condition. In some cases, movement-related symptoms may emerge or become more noticeable after antipsychotic treatment is reduced or discontinued. The likelihood and severity of discontinuation symptoms depend on the dosage, duration of treatment, and individual response. Your healthcare provider may recommend gradually reducing the dosage rather than stopping the medication abruptly. This process is called tapering and allows the body to adjust to lower medication levels. Nozinan is not considered addictive, but sudden discontinuation may cause withdrawal symptoms or a return of the condition being treated. Do not stop or reduce your medication without consulting your healthcare provider.
The time needed for Nozinan to produce noticeable benefits depends on the condition being treated, the prescribed dosage, method of administration, and individual response. Nozinan contains methotrimeprazine, a medication that affects neurotransmitters involved in thinking, behavior, nausea, and other bodily functions. Some effects develop relatively quickly, while others may require several days or weeks of treatment. When used to manage sedation and agitation, Nozinan may begin producing noticeable effects within the first few hours after an oral dose. Its sedating properties may help reduce severe agitation, restlessness, or distress in selected patients. However, experiencing sedation does not necessarily mean that the underlying psychiatric condition has fully responded to treatment. For severe nausea and vomiting, Nozinan may provide relief within several hours, depending on the dosage, method of administration, and underlying cause of symptoms. Patients receiving treatment for persistent nausea may require dosage adjustments to achieve adequate symptom control. Your healthcare provider will evaluate your response and determine whether changes to your treatment are necessary. Patients taking Nozinan for psychotic disorders may require several days or weeks before meaningful improvements become noticeable. Symptoms such as agitation and restlessness may improve earlier, while hallucinations, delusions, and disorganized thinking may take longer to respond. The full therapeutic effects vary considerably between individuals, depending on the severity of the condition and their response to medication. When used as an additional medication for selected pain conditions or in palliative care, Nozinan may provide sedative or symptom-relieving effects relatively quickly. However, its effectiveness depends on the type of symptoms being treated, the prescribed dosage, and the patient’s overall medical condition. Your healthcare provider will monitor your progress and determine whether dosage adjustments are necessary to achieve appropriate symptom relief. Because Nozinan can cause significant drowsiness, low blood pressure, dizziness, and other adverse effects, increasing the dosage without medical supervision can be dangerous. Nozinan may produce sedative and anti-nausea effects within hours, while improvements in psychotic symptoms may take several days or weeks. Continue taking the medication as prescribed and do not adjust your dosage without consulting your healthcare provider.
| Generic name: | Methotrimeprazine |
|---|---|
| Formulation: | Tablet |
| Strength(s): | 2mg, 5mg, 25mg, 50mg |
| Quantities Available: | 100, 200 |
Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.
Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.
When ordering Nozinan (methotrimeprazine) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of chronic conditions without frequent refills.
Here’s what you need to know:
Dosage and Quantity: Nozinan is available in 2 mg, 5 mg, 25 mg, and 50 mg tablets. The dosage varies depending on the condition being treated. For example, if the prescribed dosage is 50 mg taken three times daily, for a 90-day supply, you would order 270 tablets (90 days x 3 tablets per day).
Yes, we sell methotrimeprazine on our website. You can enjoy low prices when you order through us. To purchase methotrimeprazine, you will need a valid prescription from your healthcare provider. We require this to dispense the medication safely and appropriately. You can submit your prescription by mailing it to us, faxing it, or uploading it through your online account.
Yes, we ship Nozinan (methotrimeprazine) to both the United States and Puerto Rico.
Watch how Online Pharmacies Canada is helping customers save money on their medications.
Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Nozinan (Methotrimeprazine). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Nozinan (Methotrimeprazine).
REVIEWS